May 25 (Reuters) - Vita Life Sciences Ltd (VLS) :
- SEES SALES GROWTH OF 8-10% ON PREVIOUS YEAR TO AROUND $19M FOR H1
- SEES H1 EBIT GROWTH OF AROUND 15% ON PREVIOUS HALF YEAR
- SEES FY EBIT TO BE SLIGHTLY LOWER COMPARED TO FY 2017 DUE TO INCREASE INVESTMENT IN BRAND EQUITY INCLUDING ADVERTISING & PROMOTION
News: VLS Vita Life Sciences Sees H1 Sales Growth Of 8-10 pct On Previous Year
Add VLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.05 |
Change
-0.025(1.20%) |
Mkt cap ! $131.4M | |||
| Open | High | Low | Value | Volume |
| $2.06 | $2.06 | $2.03 | $58.13K | 28.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5119 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.09 | 6695 | 1 |
View Market Depth
| Last trade - 15.58pm 28/11/2024 (20 minute delay) ? |
| VLS (ASX) Chart |
